AP705A - Compositions having antiviral properties. - Google Patents

Compositions having antiviral properties. Download PDF

Info

Publication number: AP705A
Authority: AP; ARIPO
Prior art keywords: fact; composition according; nopal; fruits; acetic acid
Prior art date: 1995-03-06

Application number

APAP/P/1996/000872A

Other languages

English (en)

Other versions

AP9600872A0 (en

Inventor

Alix Roland Commin

Original Assignee

Alix Roland Commin

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-06

Filing date

1996-02-13

Publication date

1998-12-04

1996-02-13 Application filed by Alix Roland Commin filed Critical Alix Roland Commin

1996-10-31 Publication of AP9600872A0 publication Critical patent/AP9600872A0/xx

1998-12-04 Application granted granted Critical

1998-12-04 Publication of AP705A publication Critical patent/AP705A/en

Links

239000000203 mixture Substances 0.000 title claims abstract description 59
230000000840 anti-viral effect Effects 0.000 title claims description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 32
235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 16
244000060011 Cocos nucifera Species 0.000 claims abstract description 16
239000000843 powder Substances 0.000 claims abstract description 8
239000000284 extract Substances 0.000 claims abstract description 7
229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 6
239000011707 mineral Substances 0.000 claims abstract description 6
241000208223 Anacardiaceae Species 0.000 claims abstract description 5
150000003839 salts Chemical class 0.000 claims abstract description 5
241000221017 Euphorbiaceae Species 0.000 claims abstract description 4
235000013399 edible fruits Nutrition 0.000 claims description 12
240000008607 Opuntia megacantha Species 0.000 claims description 11
235000002840 Opuntia megacantha Nutrition 0.000 claims description 11
235000006538 Opuntia tuna Nutrition 0.000 claims description 11
BLKPFVWYBFDTPX-UHFFFAOYSA-N 2-(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)acetaldehyde Chemical compound C1C2C(C)(C)C1CC=C2CC=O BLKPFVWYBFDTPX-UHFFFAOYSA-N 0.000 claims description 9
241000159165 Spondias Species 0.000 claims description 9
235000004443 Ricinus communis Nutrition 0.000 claims description 7
240000000528 Ricinus communis Species 0.000 claims description 7
239000000706 filtrate Substances 0.000 claims description 7
239000004615 ingredient Substances 0.000 claims description 6
230000000798 anti-retroviral effect Effects 0.000 claims description 5
239000013535 sea water Substances 0.000 claims description 5
240000001439 Opuntia Species 0.000 claims description 4
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
239000011575 calcium Substances 0.000 claims description 2
229910052791 calcium Inorganic materials 0.000 claims description 2
150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
150000003841 chloride salts Chemical class 0.000 claims description 2
229940079593 drug Drugs 0.000 claims description 2
239000003814 drug Substances 0.000 claims description 2
239000011777 magnesium Substances 0.000 claims description 2
229910052749 magnesium Inorganic materials 0.000 claims description 2
239000011591 potassium Substances 0.000 claims description 2
229910052700 potassium Inorganic materials 0.000 claims description 2
239000011734 sodium Substances 0.000 claims description 2
229910052708 sodium Inorganic materials 0.000 claims description 2
150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
229910019142 PO4 Inorganic materials 0.000 claims 1
239000004359 castor oil Substances 0.000 claims 1
235000019438 castor oil Nutrition 0.000 claims 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
235000021317 phosphate Nutrition 0.000 claims 1
150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
239000003981 vehicle Substances 0.000 claims 1
241000700605 Viruses Species 0.000 description 28
230000002441 reversible effect Effects 0.000 description 15
230000000694 effects Effects 0.000 description 13
238000012360 testing method Methods 0.000 description 11
210000004027 cell Anatomy 0.000 description 10
239000000243 solution Substances 0.000 description 8
239000000725 suspension Substances 0.000 description 8
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 6
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 6
229960000583 acetic acid Drugs 0.000 description 6
238000011109 contamination Methods 0.000 description 6
239000002245 particle Substances 0.000 description 6
238000010790 dilution Methods 0.000 description 5
239000012895 dilution Substances 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
208000030507 AIDS Diseases 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
230000002779 inactivation Effects 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
239000002609 medium Substances 0.000 description 3
102100034343 Integrase Human genes 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
239000012979 RPMI medium Substances 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
108091006629 SLC13A2 Proteins 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
229960002555 zidovudine Drugs 0.000 description 2
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
101900297506 Human immunodeficiency virus type 1 group M subtype B Reverse transcriptase/ribonuclease H Proteins 0.000 description 1
235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
230000006735 deficit Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
230000002879 macerating effect Effects 0.000 description 1
238000005497 microtitration Methods 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
238000011533 pre-incubation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
241000894007 species Species 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
238000011282 treatment Methods 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Alternative & Traditional Medicine (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

APAP/P/1996/000872A 1995-03-06 1996-02-13 Compositions having antiviral properties. AP705A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9502595A FR2731354B1 (fr)	1995-03-06	1995-03-06	Compositions possedant des proprietes antivirales et procede d'obtention
PCT/FR1996/000230 WO1996027383A1 (fr)	1995-03-06	1996-02-13	Compositions possedant des proprietes antivirales et procede d'obtention

Publications (2)

Publication Number	Publication Date
AP9600872A0 AP9600872A0 (en)	1996-10-31
AP705A true AP705A (en)	1998-12-04

Family

ID=9476780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/1996/000872A AP705A (en)	1995-03-06	1996-02-13	Compositions having antiviral properties.

Country Status (15)

Country	Link
EP (1)	EP0768887B1 (de)
JP (1)	JPH10506124A (de)
AP (1)	AP705A (de)
AT (1)	ATE201825T1 (de)
AU (1)	AU711634B2 (de)
CA (1)	CA2189474C (de)
DE (1)	DE69613190T2 (de)
DK (1)	DK0768887T3 (de)
EA (1)	EA000112B1 (de)
ES (1)	ES2171653T3 (de)
FR (1)	FR2731354B1 (de)
GR (1)	GR3036556T3 (de)
OA (1)	OA10332A (de)
PT (1)	PT768887E (de)
WO (1)	WO1996027383A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000001398A1 (en) *	1998-07-02	2000-01-13	Nobutho Gladys Makupula	Anti-viral plant extract
US6238672B1 (en)	1999-04-23	2001-05-29	E. Excel International Inc.	Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
MY124001A (en) *	1999-04-23	2006-06-30	E Excel Int	Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
US6524626B2 (en)	1999-04-23	2003-02-25	E Excel International, Inc.	Ginseng berry topical products
US6576286B1 (en)	1999-04-23	2003-06-10	E Excel International	Cactus fruit drinks and food products
US6210738B1 (en)	1999-04-23	2001-04-03	E Excel Internatioanal Inc.	Freeze-dried ginseng berry tea
FR2926465B1 (fr) *	2008-01-17	2016-08-12	Alix Roland Commin	Composition anti-virale notamment le sida
WO2011010000A1 (fr) *	2009-07-22	2011-01-27	Alix Roland Commin	Composition antivirale et retrovirale notamment pour le traitement du sida

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0295955A2 (de) *	1987-06-18	1988-12-21	Kureha Kagaku Kogyo Kabushiki Kaisha	Lectine und antiretrovirale Arzneimittel, enthaltend die Lectine als aktive Zutaten
WO1993011217A1 (fr) *	1990-05-22	1993-06-10	Neyroud Andre	Savon pain, liquide gel antiseptique qui detruit les hiv sida
WO1993011779A1 (en) *	1991-12-12	1993-06-24	Gordon Robert Bruce Skinner	Antiviral activity of extract of cactus

1995
- 1995-03-06 FR FR9502595A patent/FR2731354B1/fr not_active Expired - Fee Related
1996
- 1996-02-13 DE DE69613190T patent/DE69613190T2/de not_active Expired - Fee Related
- 1996-02-13 EA EA199600087A patent/EA000112B1/ru not_active IP Right Cessation
- 1996-02-13 PT PT96904129T patent/PT768887E/pt unknown
- 1996-02-13 ES ES96904129T patent/ES2171653T3/es not_active Expired - Lifetime
- 1996-02-13 DK DK96904129T patent/DK0768887T3/da active
- 1996-02-13 AT AT96904129T patent/ATE201825T1/de not_active IP Right Cessation
- 1996-02-13 WO PCT/FR1996/000230 patent/WO1996027383A1/fr not_active Ceased
- 1996-02-13 AP APAP/P/1996/000872A patent/AP705A/en active
- 1996-02-13 JP JP8526645A patent/JPH10506124A/ja not_active Ceased
- 1996-02-13 EP EP96904129A patent/EP0768887B1/de not_active Expired - Lifetime
- 1996-02-13 CA CA002189474A patent/CA2189474C/fr not_active Expired - Fee Related
- 1996-02-13 AU AU48340/96A patent/AU711634B2/en not_active Ceased
- 1996-10-25 OA OA60910A patent/OA10332A/fr unknown
2001
- 2001-09-06 GR GR20010401410T patent/GR3036556T3/el not_active IP Right Cessation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0295955A2 (de) *	1987-06-18	1988-12-21	Kureha Kagaku Kogyo Kabushiki Kaisha	Lectine und antiretrovirale Arzneimittel, enthaltend die Lectine als aktive Zutaten
WO1993011217A1 (fr) *	1990-05-22	1993-06-10	Neyroud Andre	Savon pain, liquide gel antiseptique qui detruit les hiv sida
WO1993011779A1 (en) *	1991-12-12	1993-06-24	Gordon Robert Bruce Skinner	Antiviral activity of extract of cactus

Also Published As

Publication number	Publication date
WO1996027383A1 (fr)	1996-09-12
CA2189474A1 (fr)	1996-09-12
DE69613190D1 (de)	2001-07-12
EA199600087A1 (ru)	1997-09-30
AP9600872A0 (en)	1996-10-31
OA10332A (fr)	1997-10-07
FR2731354B1 (fr)	1997-05-09
EP0768887B1 (de)	2001-06-06
GR3036556T3 (en)	2001-12-31
JPH10506124A (ja)	1998-06-16
DE69613190T2 (de)	2002-01-31
EA000112B1 (ru)	1998-08-27
EP0768887A1 (de)	1997-04-23
DK0768887T3 (da)	2001-09-10
ATE201825T1 (de)	2001-06-15
CA2189474C (fr)	2003-07-29
AU4834096A (en)	1996-09-23
ES2171653T3 (es)	2002-09-16
FR2731354A1 (fr)	1996-09-13
PT768887E (pt)	2001-11-30
AU711634B2 (en)	1999-10-21

Publication	Publication Date	Title
Thakur et al.	2009	Momordica balsamina: a medicinal and neutraceutical plant for health care management
Papu et al.	2014	Medicinal values of garlic (Allium sativum L.) in human life: an overview
Alenzi et al.	2010	Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide
AP705A (en)	1998-12-04	Compositions having antiviral properties.
KR101147861B1 (ko)	2012-06-05	산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 후천성 면역결핍증의 예방 또는 치료용 조성물
Abera et al.	2018	The Significance of Garlic (Allium sativum L.) on the livelihood of the local community
Rethinam et al.	2022	Health benefits of coconut water
Wannang et al.	2005	Evaluation of anti-snake venom activity of the aqueous root extract of Securidaca longipedunculata in rats
KR20190042999A (ko)	2019-04-25	미선나무 추출물을 포함하는 골다공증 예방 및 치료용 조성물
JP6975425B2 (ja)	2021-12-01	抗ノロウイルス組成物及びその利用
Uddin et al.	2016	Correlation of thrombolytic and membrane stabilizing activities with total flavonoid content aerial parts of Spondias pinnata
KR102165239B1 (ko)	2020-10-13	미선나무 추출물을 포함하는 간보호용 조성물
KR100749941B1 (ko)	2007-08-21	고추냉이 추출물을 포함하는 간암 예방용 조성물과 건강 식품
Ahmed	2023	The Biological Activity of the Annona muricata L. Plant
Pushparathna et al.	2019	In vitro anti-inflammatory activity of Trichosanthes cucumerina fruits.
KR20010034764A (ko)	2001-04-25	후천성 면역결핍증의 예방 및 치료를 위한 허브 조성물
KR100510429B1 (ko)	2005-08-30	면역활성 증진 및 항암 효과를 갖는 혼합물의 물추출물 및그의 제조방법
WO2003035091A1 (fr)	2003-05-01	Preparation ai et son utilisation pour prevenir et traiter une infection par le virus de l'immunodeficience humaine
KR102347243B1 (ko)	2022-01-05	퀼라야 추출물을 함유하는 항바이러스용 조성물
FR2926465A1 (fr)	2009-07-24	Composition anti-virale notamment le sida
KR102186561B1 (ko)	2020-12-08	노루오줌을 유효성분으로 함유하는 혈전증 예방 또는 치료용 조성물
Jose et al.	2023	REVIEW ON CNIDOSCOLUS ACONITIFOLIUS (CHAYAMANSA)-A TRADITIONAL MEDICINAL PLANT
NUT et al.	2022	NUTRITIONAL IMPORTANCE AND THERAPEUTIC POTENTIAL OF
EP2456452A1 (de)	2012-05-30	Antivirale und retrovirale zusammensetzung, im besonderen zur behandlung von aids
Jafat et al.	2026	Assessment of annona squamosal fruit extract effect of the adverse effects of doxorubicin-induced kidney injury